Presentation TCT 2016 Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials III - Stellarex Presenter: Prakash Krishnan November 01, 2016 REGISTER for free or LOG IN to view this content Endovascular Presentation TCT 2016 Femoral Up Next Presentation TCT 2016 What Makes a Plaque Vulnerable: Morphology, Chemistry, Biologic Activity, or Ischemia? Presenter: John A. Ambrose November 01, 2016 More slides + Presentation TCT 2016 Post-TAVR Valve Thickening: Current Data and Open Questions Presenter: Hasan Jilaihawi November 01, 2016 Presentation TCT 2016 Hot: Is High Dose Due to Operator Preferences or Patient Characteristics? Presenter: Sanjog Kalra November 01, 2016 We Recommend
Presentation TCT 2016 What Makes a Plaque Vulnerable: Morphology, Chemistry, Biologic Activity, or Ischemia? Presenter: John A. Ambrose November 01, 2016
Presentation TCT 2016 Post-TAVR Valve Thickening: Current Data and Open Questions Presenter: Hasan Jilaihawi November 01, 2016
Presentation TCT 2016 Hot: Is High Dose Due to Operator Preferences or Patient Characteristics? Presenter: Sanjog Kalra November 01, 2016